Streamlining Batch Testing with Automated Immunoassays
The upcoming webinar titled
Using a Novel Automated Immunoassay to Streamline Batch Testing promises to deliver exciting advancements in the field of biopharmaceutical testing. Hosted by Xtalks, this free session will explore an alternative immunoassay technology and its comparative effectiveness against the widely used ELISA technique.
Understanding Automated Immunoassays
Automated immunoassays utilize advanced technology to improve testing efficiency and accuracy, especially during the manufacturing of monoclonal antibodies. During this process, various impurities such as host cell proteins can compromise the quality and safety of the product. Therefore, it's critical for biopharmaceutical companies to adopt reliable methods for detecting and quantifying these impurities.
Traditionally, ELISA (Enzyme-Linked Immunosorbent Assay) has been the gold standard for such testing. However, the limitations of this method regarding time consumption and resource allocation have sparked interest in automated alternatives. This webinar aims to introduce attendees to these novel automated techniques that promise to enhance the accuracy and speed of testing procedures.
What to Expect from the Webinar
Attendees will benefit from comprehensive insights shared by industry experts like Fabrice Cantais, Senior Scientist, Analytical Leader for Biologics at Servier, and Kira Hedström, Application Scientist at Gyros Protein Technologies. They will present case studies that demonstrate how automated immunoassay technology has been implemented successfully within the biopharma sector. Specific focus will be on its ability to quantify IgG titers, assess residual impurities, and evaluate product effectiveness through target binding assays.
This session will not only highlight the technological advancements but will also showcase real-world applications. Participants will have the opportunity to engage with the speakers and immerse themselves in discussions about best practices, challenges, and future directions in biopharmaceutical testing.
Benefits of Attending
By attending this webinar, participants will gain valuable knowledge about:
- - The operational benefits of utilizing automated immunoassay technology in place of traditional ELISA methods.
- - The methodology behind quantifying impurities and measuring product potency efficiently.
- - Insights into how the technology has transformed testing workflows in clinical batch release.
Moreover, this event is also an opportunity for professionals across the pharmaceutical, biotechnology, and healthcare industries to enhance their understanding and keep abreast of industry developments.
Register Now!
Mark your calendar for December 4, 2025, at 10 AM EST (4 PM CET). This engaging session promises to be an eye-opener for professionals interested in the latest innovations in immunological testing. To register for the webinar and to learn more about these transformative approaches in testing, visit the Xtalks website.
About Xtalks
Xtalks is a leading platform powering webinars and digital content for both the life sciences and healthcare communities. Each year, Xtalks hosts numerous educational events that attract industry practitioners from various backgrounds. Participants can rely on Xtalks for valuable insights that help them stay informed on evolving regulations, technologies, and clinical practices.
This webinar is not only relevant for those involved in biopharma testing, but also for anyone with an interest in modern laboratory practices and efficiencies in the biomedical field. Don’t miss this chance to learn from the experts and ensure your knowledge is at the forefront of the industry. Join us as we navigate the future of immunoassays in biopharmaceutical testing!